Learn More
ATCC Pseudomonas aeruginosa; Strain PGO2396
Supplier: ATCC BAA2113
Pseudomonas aeruginosa strain PGO2396 is a bacterial strain that was collected from the sputum sample of a cystic fibrosis patient during a Phase III clinical trial that tested the effectiveness of aerosolized Tobi (Tobramycin).
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.